نتایج جستجو برای: intravenous immunoglobulin ivig

تعداد نتایج: 141291  

Journal: :iranian journal of allergy, asthma and immunology 0
seyed hamidreza mortazavi division of allergy and clinical immunology, department of pediatrics, shiraz university of medical sciences, shiraz, iran and department of pediatrics, kermanshah university of medical sciences, kermanshah, iran. reza amin division of allergy and clinical immunology, department of pediatrics, shiraz university of medical sciences, shiraz, iran. soheyla alyasin division of allergy and clinical immunology, department of pediatrics, shiraz university of medical sciences, shiraz, iran. sara kashef division of allergy and clinical immunology, department of pediatrics, shiraz university of medical sciences, shiraz, iran. mohammad hossein karimi transplant research center, shiraz university of medical sciences, shiraz, iran. maryam babaei transplant research center, shiraz university of medical sciences, shiraz, iran.

kawasaki disease (kd) is an acute febrile systemic vasculitis of childhood characterized by elevated levels of inflammatory mediators at the acute stage. high-dose intravenous immunoglobulin (ivig) is well accepted as a conventional therapy for kd. the aim of the present study was to determine the expression level of toll like receptors (tlrs) and their corresponding signaling mediators in pbmc...

2015
José Bruno

The object of this study is to assess the IvIg (intravenous immunoglobulin) use in inflammatory systemic and immune-mediated illnesses, in patients older than 18 years in a tertiary hospital. The assessment also intends to ensure if the clinical indications matched with the evidence-based clinical guidelines recommendations of use. Analytical, observational, transversal and retrospective study ...

2013
Frances Rose R. Palabrica Shirley L. Kwong Florecita R. Padua

BACKGROUND Intravenous immunoglobulin (IVIG) is a biological product with adverse effects that appears to vary considerably among different IVIG preparations. OBJECTIVES To describe the adverse events of patients given intravenous immunoglobulin infusions. METHOD Data was collected on all patients receiving IVIG infusion at a tertiary hospital from January 2001 to December 2010. Descriptive...

2013
Akihiro Fujii Yuko Kase Chiaki Suzuki Akihito Kamizono Teruaki Imada

Intravenous immunoglobulin (IVIG), a highly purified immunoglobulin fraction prepared from pooled plasma of several thousand donors, increased anti-inflammatory cytokine IL-10 production, while decreased proinflammatory cytokine IL-12p70 production in bone-marrow-derived mouse dendritic cells (BMDCs) stimulated with lipopolysaccharide (LPS). The changes of cytokine production were confirmed wit...

2017
Kyung Lim Yoon Hae Yong Lee Jeong Jin Yu Jae Young Lee Mi Young Han Ki Yong Kim June Huh

BACKGROUND AND OBJECTIVES Intravenous immunoglobulin-SN (IVIG-SN) is a new human immunoglobulin product. Its safety is ensured by pathogen-elimination steps comprising solvent/detergent treatment and a nanofiltration process. This multicenter clinical study was designed to evaluate the efficacy and safety of combined aspirin and high-dose IVIG-SN therapy in pediatric patients with Kawasaki dise...

Journal: :iranian journal of child neurology 0
t. mahmoudian md,associate professor department of pediatric neurology,isfahan medical university m. ghofrani md,professor, department of pediatric neurology, shahid beheshti medical university

objective guillain-barre syndrome (gbs) is the most common cause of acute neuromuscular paralysis in children, its pathogenesis most probably involving an autoimmune response to schwann cell or peripheral nerve myelin antigens. steroid regimes improve demyelinating diseases such as chronic gbs. we assessed the benefit of high dose methylprednisolone (mp) combined with intravenous immunoglobulin...

Journal: :Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 2012
Gord Blackhouse Feng Xie Mitchell A H Levine Kaitryn Campbell Nazila Assasi Kathryn Gaebel Daria O'Reilly Jean- Eric Tarride Ron Goeree

BACKGROUND Idiopathic thrombocytopenic purpura (ITP) is a hematological disorder and can be classified as acute or chronic. The main goal of treatment for acute childhood ITP is the prevention of potentially fatal bleeding complications, the most serious of which is intracranial hemorrhage (ICH). Treatment options for acute childhood ITP include splenectomy, corticosteroids, and blood products ...

Journal: :The American journal of pathology 1998
C Xu B Poirier J P Duong Van Huyen N Lucchiari O Michel J Chevalier S Kaveri

Intravenous immunoglobulin (IVIg) is increasingly used in the treatment of autoimmune and inflammatory diseases, including vasculitides and Kawasaki disease. However, the outcome of IVIg interaction with endothelial cells of the vascular bed is not clear as yet. We have investigated the effect of IVIg on the in vitro activation of human endothelial cells, as assessed by cell proliferation and r...

Background and Aims: Intravenous immunoglobulin (IVIG) is one of the safest biological products, which is effective in the treatment of many diseases. This study aimed to evaluate the rational prescription pattern of IVIG based on the approved indications of the Food and Drug Administration (FDA) among teaching hospitals in Birjand, Iran. Materials and Methods: This descriptive-analytical stud...

Journal: :Expert opinion on pharmacotherapy 2011
Nortina Shahrizaila Nobuhiro Yuki

INTRODUCTION Guillain-Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis and, despite treatment, there continues to be an associated mortality and severe disability ranging from 9 to 17%. This article reviews the rationale behind the existing immunotherapy in GBS and discusses the future direction that work in this area should follow. AREAS COVERED The pathogenesis of ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید